Showing results (1671-1680 of 4,684) with videos related to
Sort By:
Pageof 469
Chemmedchem|January 21, 2010
Molecular modeling studies on the human neuropeptide S receptor and its antagonistsDiego Dal Ben, Ippolito Antonini, Michela Buccioni, et al.Chemmedchem|March 12, 2010
Design and in vitro evaluation of branched peptide conjugates: turning nonspecific cytotoxic drugs into tumor-selective agentsChiara Falciani, Jlenia Brunetti, Chiara Pagliuca, et al.Chemmedchem|November 19, 2009
Discovery of potent vascular endothelial growth factor receptor-2 inhibitorsAthanasios Papakyriakou, Maria E Katsarou, Maria Belimezi, et al.Chemmedchem|January 1, 2010
Semisynthetic latrunculin derivatives as inhibitors of metastatic breast cancer: biological evaluations, preliminary structure-activity relationship and molecular modeling studiesMohammad A Khanfar, Diaa T A Youssef, Khalid A El SayedChemmedchem|November 28, 2009
Neuroprotective effects of N-alkyl-1,2,4-oxadiazolidine-3,5-diones and their corresponding synthetic intermediates N-alkylhydroxylamines and N-1-alkyl-3-carbonyl-1-hydroxyureas against in vitro cerebral ischemiaAlain Cesar Biraboneye, Sebastien Madonna, Pamela Maher, et al.Chemmedchem|November 3, 2009
The tertiary amine nitrogen atom of piperazine sulfonamides as a novel determinant of potent and selective beta3-adrenoceptor agonistsMaria Grazia Perrone, Laura Bleve, Ernesto Santandrea, et al.Chemmedchem|September 30, 2014
Design and synthesis of N-acylated aza-goniothalamin derivatives and evaluation of their in vitro and in vivo antitumor activityRosimeire Coura Barcelos, Julio Cezar Pastre, Débora Barbosa Vendramini-Costa, et al.Chemmedchem|December 11, 2014
Promiscuity and the conformational rearrangement of drug-like molecules: insight from the protein data bankMichael W He, Patrick S Lee, Zachary K SweeneyChemmedchem|January 13, 2015
Natural products as zinc-dependent histone deacetylase inhibitorsShuai Tan, Zhao-Peng LiuChemmedchem|November 15, 2014
The discovery of a highly selective 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one SIRT2 inhibitor that is neuroprotective in an in vitro Parkinson's disease modelPaolo Di Fruscia, Emmanouil Zacharioudakis, Chang Liu, et al.Pageof 469